News
Beyond Anxiety and Depression: A New Framework for Mental Health in Cancer Care
Emerging research suggests that understanding psychological wellbeing in people affected by cancer requires looking beyond traditional diagnostic categories. A cancer diagnosis is far more than a medical event. It can disrupt every aspect of a person's life, reshaping relationships, work,…
Lung tumours found to drive cachexia through direct brain signalling
A mouse model of lung cancer has uncovered a potential new therapeutic strategy for treating cancer cachexia. The study, published in Science on 2 July, found that Lkb1-mutant lung tumours—a common subtype of lung cancer—can communicate directly with the brain…
The Patient’s Voice May Be One of Oncology’s Best Prognostic Tools
Large meta-analysis suggests patient-reported outcomes complement traditional clinical assessment. Despite advances in imaging, molecular profiling, and biomarkers, accurately estimating how long a patient with cancer is likely to survive remains challenging. Now, a large analysis involving data from more than…
Life After Cancer Has No Borders: Is Moving Abroad as an AYA a Good Idea?
What moving across eight countries taught me about survivorship, resilience, and the hidden barriers facing young adult cancer survivors. When Cancer Changes Everything Having cancer means that the life you know—your dreams, hobbies, relationships, and plans for the future—may suddenly…
Protecting Europe’s Cancer Care Model in a Changing World
Key discussions and priorities from the 2026 Cancer Patients Europe Annual Meeting As Europe faces growing pressure on its healthcare systems, Cancer Patients Europe (CPE) brought together patient representatives, policymakers, clinicians, researchers, and industry leaders in Brussels from 24 to…
Sixteen Years Clear, Then it Came Back: A Husband’s Reckoning with Cancer, Faith, and the Ordinary Courage of Carrying On
For sixteen years, cancer became something we spoke about in the past tense. My wife, Lynn, had survived a rare smooth-muscle cancer (leiomyosarcoma) after two operations in 2009. Year after year the scans came back clear. Gradually, we stopped living…
In Memoriam: Dr Mary Buchanan (1929–2026)
The European cancer community has lost one of its most influential voices for breast cancer advocacy. Dr. Mary Buchanan—physician, advocate, and one of the founding figures of Europa Donna – The European Breast Cancer Coalition—passed away on 18 June 2026.…
Oncology Couch: Questions, Answers, and the Space in Between
To patients and oncologists alike: Are there questions living inside you that you have not been asking out loud? Could it be that you do not even know what questions to ask? Are there answers you have arrived at privately…
CancerWorld #118 (August 2026)
We often describe progress in oncology through the language of discovery. Scientific breakthroughs. Technological innovation. Deeper biological insight. These advances have transformed medicine, helping millions of people live longer and better than ever before. Yet alongside every scientific breakthrough, a…
Could GLP-1 Drugs Slow Cancer Spread? New Study Offers Encouraging Clues
Treatment with GLP-1 receptor agonists (GLP-1RAs) was associated with a significantly lower risk of progression to metastatic disease in non–small cell lung cancer (NSCLC), breast cancer, colorectal cancer (CRC), and hepatocellular carcinoma (HCC). The study, presented at the 2026 American…